New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control
Recruiting now
This is a first-in-human study to test the safety and find the right dose of a new drug called FS-8002 in people with advanced solid tumors. It will enroll 66 patients whose cancer has progressed despite standard treatments. The main goal is to see how much of the drug the body c…
Phase: PHASE1 • Sponsor: Shanghai Pushi Medical Science Co. Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC